Last reviewed · How we verify

DaZhu Rhodiola Rosea Capsule

Beijing Anzhen Hospital · FDA-approved active Small molecule

DaZhu Rhodiola Rosea Capsule is a Herbal adaptogen Small molecule drug developed by Beijing Anzhen Hospital. It is currently FDA-approved for Stress-related fatigue and mental exhaustion, Cognitive performance and concentration enhancement, Mood support and mild depression symptoms.

Rhodiola rosea extract enhances stress resilience and mental performance by modulating neurotransmitter systems and reducing cortisol-mediated stress responses.

Rhodiola rosea extract enhances stress resilience and mental performance by modulating neurotransmitter systems and reducing cortisol-mediated stress responses. Used for Stress-related fatigue and mental exhaustion, Cognitive performance and concentration enhancement, Mood support and mild depression symptoms.

At a glance

Generic nameDaZhu Rhodiola Rosea Capsule
SponsorBeijing Anzhen Hospital
Drug classHerbal adaptogen
ModalitySmall molecule
Therapeutic areaPsychiatry / Neurology / General wellness
PhaseFDA-approved

Mechanism of action

Rhodiola rosea is an adaptogenic herb that contains bioactive compounds (salidroside, rosavins) which are believed to regulate serotonin, dopamine, and norepinephrine levels in the central nervous system. It may also reduce hypothalamic-pituitary-adrenal (HPA) axis hyperactivity and cortisol elevation during stress, thereby improving cognitive function, mood, and physical endurance.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about DaZhu Rhodiola Rosea Capsule

What is DaZhu Rhodiola Rosea Capsule?

DaZhu Rhodiola Rosea Capsule is a Herbal adaptogen drug developed by Beijing Anzhen Hospital, indicated for Stress-related fatigue and mental exhaustion, Cognitive performance and concentration enhancement, Mood support and mild depression symptoms.

How does DaZhu Rhodiola Rosea Capsule work?

Rhodiola rosea extract enhances stress resilience and mental performance by modulating neurotransmitter systems and reducing cortisol-mediated stress responses.

What is DaZhu Rhodiola Rosea Capsule used for?

DaZhu Rhodiola Rosea Capsule is indicated for Stress-related fatigue and mental exhaustion, Cognitive performance and concentration enhancement, Mood support and mild depression symptoms.

Who makes DaZhu Rhodiola Rosea Capsule?

DaZhu Rhodiola Rosea Capsule is developed and marketed by Beijing Anzhen Hospital (see full Beijing Anzhen Hospital pipeline at /company/beijing-anzhen-hospital).

What drug class is DaZhu Rhodiola Rosea Capsule in?

DaZhu Rhodiola Rosea Capsule belongs to the Herbal adaptogen class. See all Herbal adaptogen drugs at /class/herbal-adaptogen.

What development phase is DaZhu Rhodiola Rosea Capsule in?

DaZhu Rhodiola Rosea Capsule is FDA-approved (marketed).

What are the side effects of DaZhu Rhodiola Rosea Capsule?

Common side effects of DaZhu Rhodiola Rosea Capsule include Headache, Dizziness, Dry mouth, Insomnia (if taken late in day).

Related